FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN MANAGEMENT SYSTEM

MDR report key: 15779812 · Received November 11, 2022

Report

Report Number
3004464228-2022-17655
Event Type
Malfunction
Date Received
November 11, 2022
Date of Event
September 5, 2022
Report Date
September 12, 2022
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K192659
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS RETURNED NOT DEPLOYED. THE DOWNLOAD DATA SHOWS THE DEVICE COMPLETED 45 FIRST PRIME PULSES AND WAS THEN DEACTIVATED AFTER THE COMPLETION OF FIRST PRIME. DURING INVESTIGATION THE DEVICE DEPLOYED NORMALLY UPON MANUAL ROTATION OF THE RATCHET GEAR. NO DAMAGES OR DEFECTS WERE OBSERVED THAT WOULD RESULT IN A FAILURE OF THE CANNULA TO DEPLOY.D4 - SERIAL NO CHANGED FROM 0870884 TO 0670684. D4 - UNIQUE IDENTIFIER (UDI) # CHANGED FROM (B)(4).

Additional Manufacturer Narrative · 0

WE ARE UNABLE TO CONFIRM THE REPORTED NEEDLE MECHANISM FAILURE OR DETERMINE ITS ROOT CAUSE. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS. PER SUPPORT TICKET-337500 ¿THE FDA CDRH APPLICATION TEAM RECOGNIZES THAT INDUSTRY FACED SUBMISSION ISSUES AND DELAY IN ACK3 RESPONSES DURING THE MONTH OF SEPTEMBER 2022.

Description of Event or Problem · 0

IT WAS REPORTED THE NEEDLE DID NOT DEPLOY, INDICATING A FAILURE OF THE NEEDLE MECHANISM. THE PATIENT'S BLOOD GLUCOSE LEVELS WERE UNAFFECTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1285948 OMNIPOD INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 19191 L50307

Patients

Seq Age Sex Outcome Treatment
1 Unknown